Several Eph receptors, including EphA5 and most commonly EphA3, are mutated in lung cancer [7], and EphA3 mutations have also been reported in melanoma, glioblastoma, colon, liver, pancreatic, and ovarian cancers [63]. This evidence concerns the gene EPHA3 and glioblastoma.